Screener
Arcus Biosciences RCUS Accrued Research And Development Expenses Current
Accrued Research And Development Expenses Current at other companies
Other financials
Where this comes from
Reported directly by Arcus Biosciences in its filing.
Tagged under the XBRL concept rcus:AccruedResearchAndDevelopmentExpensesCurrent.
The source filing: Arcus Biosciences’s 10-Q, filed August 5, 2026.
- Filed
- Aug 5, 2026, 4:11 PM EDT
- Fiscal quarter
- Q2 FY2026
- Calendar quarter
- Q2 2026
- Accession
- 0001724521-26-000044
FAQ
- What is Arcus Biosciences's accrued research and development expenses current?
- Arcus Biosciences (RCUS) reported accrued research and development expenses current of $98M in Q2 2026.
- How has Arcus Biosciences's accrued research and development expenses current changed year-over-year?
- Arcus Biosciences's accrued research and development expenses current increased by 60.7% year-over-year, from $61M to $98M.
- What is the long-term trend for Arcus Biosciences's accrued research and development expenses current?
- Over 5 years (2020 to 2025), Arcus Biosciences's accrued research and development expenses current has grown at a 37.2% compound annual growth rate (CAGR), from $18.31M to $89M.
- What does accrued research and development expenses current mean?
- Accrued Research And Development Expenses Current as reported by Arcus Biosciences, Inc..
Ask your AI about Arcus Biosciences's accrued research and development expenses current.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude